Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday, 4 September 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (CSE: $XCX.C) (CSE: $CNNA.C) (TSX: $VFF.TO) (NYSE: $ACB)


Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (CSE: $XCX.C) (CSE: $CNNA.C) (TSX: $VFF.TO) (NYSE: $ACB)



Delta, Kelowna, BC –September 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today's podcast overview/transcript

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced today that it has commenced construction of a 9,800 m2 (105,486 sq.ft) cultivation and processing facility in Juan Lacaze, Uruguay. With a production capacity of 17 tons per year, the Company's investment in this state-of-the-art facility represents a significant increase in Khiron's total production capacity, strengthening its ability to export and supply cannabis to key international markets, including Brazil and Europe. Construction is underway and is scheduled for completion in mid Q3 2020
Located strategically within an hour's distance from the international airport and port, the facility will include 8,000 m2 of covered area for cultivation, where controlled conditions of irrigation, temperature, humidity and light will be implemented for optimum crop development. An 1,800 m2 processing plant will also be built on site for drying and processing crops, with pharmaceutical-grade design standards in place to ensure quality control across the analysis process. The cultivation area and processing plant will be built to meet the requirements of Good Agricultural Practices (GAP) and Good Manufacturing Practices (GMP), respectively, in keeping with Khiron's continued expertise and core commitment to regulatory and operational compliance.  
Alvaro Torres, CEO and Director of Khiron Life Sciences, commented: "With construction of our facility in Juan Lacaze, we are actively executing on our strategy to build a dominant position in Latin America and further expand our global reach. Through its inclusion in the Mercosur trade bloc, Uruguay is poised to become a key source to supply the global medical cannabis industry. Our production in the country will target domestic use in Uruguay and export across one of the world's largest trading blocs, beginning with export to Brazil, home to 208 million people, and from there, we expect to move quickly across the bloc's trading countries in Latin America."         
Uruguay was the first country globally to establish cannabis legislation. Building upon Khiron's previously announced acquisition of NettaGrowth International Inc. and its wholly-owned subsidiary Dormul S.A., which obtained the first licence in Uruguay to produce and export medical cannabis with THC for commercialization, the Company is now initiating construction of the cultivation and processing facility. Khiron has also begun pre-clinical studies in the country as part of an initiative co-sponsored by the government of Uruguay using the Company's strains. Identified as one of the most significant private-public medical cannabis studies underway in Latin America, the research program has received matching government funding for its medical innovation.

AMP German Cannabis Group Inc. (formerly "Chinook Tyee Industry Limited") (CSE: XCX) announced the commencement of trading of its common shares on the Canadian Securities Exchange (CSE).  The Company's common shares were delisted from the TSX Venture Exchange at the close of market on September 3, 2019.  The Company also announces that it has updated investment policy to enhance shareholder value from investments in the European medical cannabis industry.

Specifically, the Company invests in businesses that supply the German market with European Union – Good Manufacturing Practices ("EU-GMP") certified medical cannabis. The Company's medical cannabis investment portfolio consists of AMP Alternative Medical Products GmbH ("AMP Germany"), whose business is to purchase EU-GMP certified medical cannabis from Canada for distribution in Germany, and Alternative Medical Products Switzerland GmbH ("AMP Switzerland"), whose business is to develop agreements to supply the German market with cannabis cultivated from Switzerland.

Mr. Alex Blodgett, CEO of AMP commented "AMP's current European investments in the medical cannabis industry have been made to supply Germany with EU-GMP cannabis which has been forecasted to be a $9-billion market by 2028.  AMP is the only listed company that focuses solely on supplying Germany with EU-GMP medical cannabis."
Dr. Stefan Feuerstein, Managing Director of AMP Germany commented, "AMP Germany plans to be a significant importer of EU-GMP cannabis to Germany from Canada.  Canada has become the second largest supplier of EU-GMP cannabis to Germany since legalization of medical cannabis in 2017."

Mr. Claudio Morandi, Managing Director of AMP Switzerland commented, "It is legal to cultivate cannabis with THC <1.0% in Switzerland, which has created an emerging cannabis industry. AMP Switzerland is developing sources of nutraceutical and EU-GMP cannabis for export to Germany once applicable laws permit such transactions."

CannaOne Technologies Inc. (CSE: CNNA) (OTC: CNONF) announced that it has entered into a Letter of Intent to acquire 100% interest in Real Life Sciences Inc.

On April 23rd, 2019, CannaOne Technologies announced a formal partnership with Real Life Sciences to launch and operate the BWell CBD online marketplace in the US. Under the terms of this agreement Real Life Sciences acted as local managing partners for the BWell online marketplace providing strategic management, financial and business development expertise. As the managing partner of the BWell Marketplace, Real Life Sciences maintained a 75.1% ownership interest.

CannaOne Technologies CEO, Mr. Riby-Williams, commented "Real Life Sciences' expertise, vast network and strong relationships within the US has brought substantial value to the BWell marketplace during the past months and has been a key factor in the early launch for the business. BWell (www.thebwellmarket.com) is now capable of immediate sale and delivery of 140 high quality CBD products at extremely competitive prices to thousands of potential households in US.  We believe that this infrastructure and knowledge contributed by Real Life Sciences to date provides substantial baseline support towards our Company now acquiring a sole ownership stake in the BWell marketplace that will assist to potentially provide long term substantial value to our shareholders."

Under the terms of the LOI, following an extended period of Due Diligence, CannaOne Technologies has agreed to purchase Real Life Sciences for $2,000,000 CAD, such payment to be made in full through the issuance Company shares priced at a 20% discount to the market as at the date of Closing. The Closing Date for this transaction is set for October 25, 2019.

Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has entered into a supply agreement with the British Columbia Liquor Distribution Branch (BCLDB) to supply the BCLDB with Pure Sunfarms-branded cannabis products for the recreational market in the Province of British Columbia.

Pure Sunfarms will begin shipping packaged product to the BCLDB, as well as the Ontario Cannabis Retail Corporation (the "OCRC", operating as the Ontario Cannabis Store), with whom it entered into a supply agreement in February 2019, as soon as possible upon receipt of its license amendment permitting sales and distribution directly to provincial/territorial wholesalers and authorized private retailers in accordance with provincial/territorial frameworks in Canada (sometimes referred to as a "packaging license").

Combined, Ontario and British Columbia comprise more than half of Canada's population, with Ontario (Canada's most populated province) and British Columbia (Canada's third most populated province) comprising more than 38% and more than 13% of Canada's population, respectively). Pure Sunfarms also continues to advance discussions with other provincial distributors for potential supply agreements.

"The announcement of today's supply agreement with the BCLDB represents a major milestone for Pure Sunfarms," said Mandesh Dosanjh, President and Chief Executive Officer, Pure Sunfarms. "We are proudly B.C.-based, cultivating cannabis to the highest standards by the most experienced growers in the industry, and look forward to having Pure Sunfarms product available in our home province."

"Pure Sunfarms is already one of Canada's largest cannabis producers, with an outstanding reputation for quality, consistency, safety and reliability," said Michael DeGiglio, CEO, Village Farms International.  "This supply agreement for Canada's third most populous province will significantly expand Pure Sunfarms' market reach when it begins sales directly to provincial and territorial wholesalers, taking the next step in establishing Pure Sunfarms as a premiere national brand with Canadian cannabis consumers."

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) announced today that on September 3, 2019, Aurora disposed of its remaining 28,833,334 shares, representing 10.5% of the issued and outstanding shares of The Green Organic Dutchman Holdings Ltd ("TGOD"), at a price of $3.00 per share for aggregate gross proceeds of $86.5 million. The completion of the sale of TGOD shares represents an approximate 50% internal rate of return for the Company. As a result of this transaction, Aurora no longer holds any shares of TGOD, however does continue to hold warrants to purchase 16,666,667 shares of TGOD.

"Aurora has a broad portfolio of strategic investments that allow us to participate in opportunities throughout the cannabis sector, while providing the company with non-dilutive access to capital," said Terry Booth, CEO of Aurora. "We evaluate our investment portfolio on a regular basis to make sure it continues to align with our investment strategy and corporate priorities. When we acquired Whistler Medical Marijuana Corporation – an iconic and premium organic cannabis producer – our interest in TGOD became less important to our core strategy. Our return on our TGOD investment is significant and will add non-dilutive capital and further enhance our strategy to remain a dominant force in the global cannabis industry."

Today’s podcast Sponsor:
Today’s podcast was sponsored by CBDollars. CBDollars is the first group of its kind designed to turn everyday people into entrepreneurs of one the largest, most profitable industries that will ever happen in this country. CBDollars will teach its members how to invest in the cannabis industry through stocks, ETFs, and as Angel Investors; start a wholesale store for a brick and mortar business; start an online store as a dropshipper;  private label your own products from edibles to beauty & More. Join CBDOLLARS to lean more.  https://www.facebook.com/groups/2117105128415627/






Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Today’s podcast was sponsored by CBDollars.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411




 Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories



Tuesday, 3 September 2019

Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) (XETR: TH8) Announces Corporate Update

Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) (XETR: TH8) Announces Corporate Update

Investorideas.com - CSE New Cannabis Listing: AMP German Cannabis Group (XCX)

Investorideas.com - CSE New Cannabis Listing: AMP German Cannabis Group (XCX)

Investorideas.com - Cannabis Stock News: GrowGeneration (OTCQX: $GRWG) Purchases All the Assets of Grand Rapids Hydroponics

Investorideas.com - Cannabis Stock News: GrowGeneration (OTCQX: $GRWG) Purchases All the Assets of Grand Rapids Hydroponics

Investorideas.com - Cannabis Deal Tracker

Investorideas.com - Cannabis Deal Tracker

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $DN.TO) (OTCQX: $VRNDF) (OTCQB: $GBLX) (TSX: $TGOD.TO) (OTC: $TGODF), (OTCQB: $SING)


Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $DN.TO) (OTCQX: $VRNDF) (OTCQB: $GBLX) (TSX: $TGOD.TO) (OTC: $TGODF), (OTCQB: $SING)



Delta, Kelowna BC –September 3, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at


Today's podcast overview/transcript

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, The Assembly of First Nations (AFN) is convening its first ever National Cannabis Summit on September 4-5, 2019 in Vancouver British Columbia on the territory of the Musqueam, Squamish and Tsleil-Waututh Nations.  Hundreds of delegates will gather to engage on the latest information and research relating to First Nations and cannabis, including key issues in areas like jurisdiction over sales and regulation, health impacts, social development impacts and economic development.  
The Summit is taking place at the Westin Bayshore Hotel located at 1601 Bayshore Drive.
The federal government passed the Cannabis Act and related legislation in 2018 and legal cannabis is now a reality. However, there are many issues and questions involving First Nations and cannabis that have not been properly addressed. The AFN's first ever National Cannabis Summit will be one of the most comprehensive examinations of the issues and the path forward to date. Delegates attending the Cannabis Summit will have the opportunity to hear from a number of high-profile speakers on many topics addressing the gaps in cannabis legislation, economic opportunities and First Nations jurisdiction and governance.  The Summit will advance the dialogue around First Nations and cannabis, inclusive of all approaches and perspectives on cannabis legalization.
A full agenda is available on the AFN website at www.afn.ca


DELTA 9 CANNABIS INC. (TSX:DN.TO) (OTCQX: VRNDF) announced that on August 30, 2019 it received its renewal license from Health Canada for a term of three years. This license authorizes Delta 9 to cultivate, process and sell cannabis from its Winnipeg production facility. The Company also provided investors with an update on cannabis oils sales, cannabis pre-rolls sales, and new product development.

The Company, through its subsidiary, Delta 9 Bio-Tech Inc. has received its renewed Standard Cultivation and Standard Processing license for cannabis from Health Canada. The Company has fulfilled Health Canada's rigorous specifications, and successfully passed all inspections.

"Delta 9 employees have worked hard to meet the requirements within Health Canada's strictly regulated licensing environment. It speaks to the professionalism of our team that it has maintained the high standards of safety, quality and security in accordance with Health Canada's regulations for licensed producers," said John Arbuthnot, Chief Executive Officer of Delta 9.

The Company has also received approval from Health Canada for sales of cannabis oil products. The Company has already completed production of several initial batches of its "Odyssey" and "Oasis" lines of ingestible oils and will proceed with sales of these products in the medical and recreational use cannabis markets.

In June this year the Company launched its "Bliss" line of pre-rolled cannabis products, which consist of blended cannabis flower, rolled in a cigarette format, or "joint" for sale in the medical and recreational use cannabis markets. To date the Company has produced and sold over 75,000 cannabis pre-rolls.

"It is management's belief that these products will become an increasingly important component of the medical and recreational use cannabis markets in the future," said John Arbuthnot, Chief Executive Officer of Delta 9. "A continually expanding line of high-quality cannabis products is a major goal for the Company over this year and this is the first of what we hope are several milestones in our progress."

Delta 9 has also acquired an exclusive license in Canada to manufacture and sell products made with the patented technology of Nanosphere Health Sciences Inc. for the delivery of cannabinoids via nanoparticle technology. The two companies are in the process of developing the first product for Canada; an intraoral cannabis oil containing cannabinoid nanoparticles.

The NanoSphere delivery system for cannabis works by nano-encapsulating active ingredients in phospholipid membranes for transportation through the skin and mucosa into the bloodstream within minutes. Cannabis applications of the technology include transdermal viscous gels, intranasal products and intraoral products, all of which provide rapid results, precise dosages and high bioavailability. The NanoSphere delivery system of cannabis can eliminate the need for inhalation or ingestion of cannabis, offering users a potentially safer and more effective method of consumption.

GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations that govern the program of growing marijuana for scientific research under DEA registration. GB Sciences is one of just 33 companies that applied to the DEA to become registered under the Controlled Substances Act (CSA) to grow marijuana in order to supply DEA-registered researchers in the United States. Last week, after a three-year delay and following pressure by Congress, patients and researchers, the DEA announced that it will move forward with creating revised regulations and with reviewing the applications.

"We are well-positioned to meet and exceed the DEA's criteria, and we intend to aggressively pursue federal licensure," said Dr. Andrea Small-Howard, Chief Science Officer and Director of GB Sciences. "The sophistication of our facilities, our team's deep scientific experience, and our groundbreaking cannabinoid therapies are unparalleled in the United States."

According to the letter from the DEA, it is looking to facilitate research, advance scientific understanding about the effects of marijuana, and potentially aid in the development of safe and effective drug products that may be approved for marketing by the Food and Drug Administration.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), announced that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new hybrid greenhouse located in Hamilton, Ontario. The 123,000 square foot state-of-the-art facility will serve to increase TGOD's premium organic cannabis production as it expands its sales in Canada.

TGOD's hybrid greenhouse is the fruit of years of research and development. From its cutting-edge climate control systems and water recapture systems to LED lighting, it combines the latest technologies with natural elements such as living soil and natural sunlight.  This organic growing facility has a much better environmental footprint and lower waste than traditional large-scale cannabis growing.

"We are thrilled to start using this purpose-built hybrid greenhouse as we ramp up our production of premium organic cannabis, an underserved segment of the market," commented Brian Athaide, CEO of TGOD.  "Our team pioneered the concept of growing organic cannabis at scale; this hybrid greenhouse has been artfully designed for organic cultivation, allowing us to reliably produce clean, safe and non irradiated cannabis."

The new facility is the third phase of TGOD's Hamilton site, measuring 166,000 square feet with an annual production capacity of 17,500 kgs of premium organic cannabis.  In line with its commitment to sustainability, TGOD aims to have the building LEED certified.
The Company is also seeking an eGMP certification for this facility in order to allow for global exports, as laws and regulations permit.

SinglePoint Inc. (OTCQB: SING) announced that its subsidiary Direct Solar of America is planning along with GSX International Group and other larger corporations a first of its kind Hemp distribution center. Direct Solar of America will provide all energy solutions to production and distribution centers along with energy solutions to independent farmers in the co-op. Additionally, Direct Solar of America will facilitate the selling or assigning of ITCs between the farmers and centers or other third parties.

The opportunity to expand into the hemp market represents an opportunity to enter a market that is projected to be a multi-billion dollar market in just a few short years. An organization that can effectively combine the resources of small hemp farmers and establish centralized processing and distribution centers could corner the market on hemp processing for the foreseeable future. Combined with the current tax incentives offered through ITCs and Opportunity Zones, organizations that can access both will stand to reap the biggest profits.


The overall profit potential is enormous given the current solar tax incentives along with opportunity zone exemptions. The project is projected to be fully profitable within 3-4 growing cycles. Southern farmers will have multiple growing cycles during the year, while northern farmers will be traditionally limited to one per season. The real benefit of this structure is to take advantage of the tax exemptions currently available for opportunity zone development. It is this financial incentive that will make the project profitable within 24-36 months.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories


Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market

Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market